Molecular Partners AG Statistics
Total Valuation
Molecular Partners AG has a market cap or net worth of CHF 167.30 million. The enterprise value is 11.22 million.
Market Cap | 167.30M |
Enterprise Value | 11.22M |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
Earnings Date | Oct 25, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Molecular Partners AG has 33.19 million shares outstanding. The number of shares has increased by 13.89% in one year.
Shares Outstanding | 33.19M |
Shares Change (YoY) | +13.89% |
Shares Change (QoQ) | +4.75% |
Owned by Insiders (%) | 4.92% |
Owned by Institutions (%) | 13.97% |
Float | 17.33M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 21.11 |
PB Ratio | 1.08 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.19 |
EV / Sales | 1.43 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -0.18 |
Financial Position
The company has a current ratio of 14.58, with a Debt / Equity ratio of 1.96.
Current Ratio | 14.58 |
Quick Ratio | 14.30 |
Debt / Equity | 1.96 |
Debt / EBITDA | n/a |
Debt / FCF | -0.05 |
Interest Coverage | -2,136.93 |
Financial Efficiency
Return on equity (ROE) is -31.88% and return on invested capital (ROIC) is -21.00%.
Return on Equity (ROE) | -31.88% |
Return on Assets (ROA) | -19.31% |
Return on Capital (ROIC) | -21.00% |
Revenue Per Employee | 48,531 |
Profits Per Employee | -355,716 |
Employee Count | 162 |
Asset Turnover | 0.04 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.97% in the last 52 weeks. The beta is 0.61, so Molecular Partners AG's price volatility has been lower than the market average.
Beta (5Y) | 0.61 |
52-Week Price Change | -0.97% |
50-Day Moving Average | 5.71 |
200-Day Moving Average | 4.38 |
Relative Strength Index (RSI) | 37.82 |
Average Volume (20 Days) | 12,020 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Molecular Partners AG had revenue of CHF 7.86 million and -57.63 million in losses. Loss per share was -1.75.
Revenue | 7.86M |
Gross Profit | -42.85M |
Operating Income | -61.97M |
Pretax Income | -57.63M |
Net Income | -57.63M |
EBITDA | -61.05M |
EBIT | -61.97M |
Loss Per Share | -1.75 |
Balance Sheet
The company has 159.13 million in cash and 3.05 million in debt, giving a net cash position of 156.08 million or 4.70 per share.
Cash & Cash Equivalents | 159.13M |
Total Debt | 3.05M |
Net Cash | 156.08M |
Net Cash Per Share | 4.70 |
Equity (Book Value) | 155.57M |
Book Value Per Share | 4.69 |
Working Capital | 154.24M |
Cash Flow
In the last 12 months, operating cash flow was -61.95 million and capital expenditures -702,000, giving a free cash flow of -62.65 million.
Operating Cash Flow | -61.95M |
Capital Expenditures | -702,000 |
Free Cash Flow | -62.65M |
FCF Per Share | -1.89 |
Margins
Gross Margin | n/a |
Operating Margin | -788.23% |
Pretax Margin | -732.97% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -796.91% |
Dividends & Yields
Molecular Partners AG does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -13.89% |
Shareholder Yield | -13.89% |
Earnings Yield | -34.71% |
FCF Yield | -37.45% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |